Randomized Controlled Trial of Interventions to Improve Follow-up for Latent Tuberculosis Infection After Release From Jail

Open Access
Publisher Website
Google Scholar
Abstract
TREATMENT OF persons with latent tuberculosis (TB) infection (LTBI) to prevent progression to disease is a critical component of TB control efforts in the United States.1,2 The highest risk for progression is among the recently infected3; among immigrants from countries with high rates of TB, in particular within the first 5 years following immigration4,5; among intravenous injection drug users6,7; and among persons with clinical conditions such as the human immunodeficiency virus.8